The global specialty generics market size was valued at USD 69.90 billion in 2022 and is expected to grow at a compounded annual growth rate (CAGR) of 9.9% from 2023 to 2030. Increasing adoption of specialty generic medicines for the treatment of complex chronic diseases such as hepatiti... Read More »
July 2022The global insulin market size was estimated at USD 20.35 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 1.5% from 2022 to 2030. The insulin market is witnessing growth due to factors such as the increasing incidence of diabetes and formulation advan... Read More »
July 2022The global small molecule API market size was valued at USD 175.31 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 5.44% from 2022 to 2030. Some of the major factors propelling the market are the growing demand for small molecule drugs in the market ... Read More »
July 2022The global cellular immunotherapy market size was valued at USD 6.13 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 22.41% from 2022 to 2030. Some of the major factors propelling the market growth are the development of advanced cell-based therapies... Read More »
July 2022The North America legal marijuana market size was valued at USD 13.2 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 15.0% from 2023 to 2030. Across North America, cannabis legitimization has brought about a massive change in the market... Read More »
June 2022The global aminoglycosides market size to be valued at USD 1.68 billion by 2022 and is expected to grow at a compound annual growth rate (CAGR) of 3.5% during the forecast period, owing to rising incidence of bacterial infections caused by gram-positive and gram-negative bacteria. Usage ... Read More »
June 2022The Missouri medical cannabis market size was valued at USD 394.1 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 21.40% from 2023 to 2030. In Missouri, medical cannabis was legalized in November 2018. The factors contributing to market expansion... Read More »
June 2022The Mexico medical cannabis market size was valued at USD 4.8 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 20% from 2023 to 2030. Various countries have begun to liberalize marijuana and hemp regulations, which is expected to stimulate market growt... Read More »
June 2022The North America, Europe, and Asia Pacific legal cannabis market size was valued at USD 18.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 22.3% from 2023 to 2030. On the economic front, recreational-use marijuana legalization will help create new job possibilities and add sig... Read More »
June 2022The global dermatological drugs market size was valued at USD 17.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 10.8% from 2022 to 2028. The key factors driving the global dermatological drug market are parasites, fungus, and other microorganisms living on the skin; bacteria t... Read More »
May 2022The global legal cannabis market size was valued at USD 22.1 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 25.5% from 2023 to 2030. The increasing rate of legalization of cannabis and acceptance of its use in the medical field are the key factors du... Read More »
April 2022The Europe complementary and alternative medicine market size was valued at USD 27.44 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 20.89% from 2021 to 2028. Complementary and alternative medicine (CAM) is considered a traditional treatment and the ... Read More »
December 2021The North America sports nutrition market size was valued at USD 12.6 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.4% from 2021 to 2028. Increasing awareness about the health benefits of consuming sports nutrition products among bodybuilders and ... Read More »
November 2021The Europe pharmaceutical market size was valued at USD 282.75 billion in 2020 and is expected to expand at a compound annual growth rate(CAGR)of 5.4% from 2021 to 2028. The growth can be attributed to theincreasing healthcare expenditure, a surge in R&D investments, and the emergenc... Read More »
October 2021The North America and Europe medical foods market size was valued at USD 11.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 4.3% from 2021 to 2028. Some of the drivers of the market are the rising geriatric population, the increasing prevalence of c... Read More »
September 2021The Indiana homecare enteral feeding formula market size was valued at USD 70.8 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.6% from 2021 to 2028. The demand for enteral feed formulations, such as the growing geriatric population and the rising p... Read More »
August 2021The global COVID-19 vaccine development tools market size was valued at USD 16.0 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.6% from 2021 to 2028. The market is expected to maintain its momentum in the coming future, attributive to the heavy inf... Read More »
July 2021The Tunisia pharmaceutical market size was estimated at USD 1.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 12.9% from 2021 to 2028. The market is driven by the presence of various developed and integrated facilities that promote R&D, producti... Read More »
June 2021The global B2B sports nutrition market size was valued at USD 2.0 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.8% from 2021 to 2028. The rising demand for nutrition products in the form of protein bars, sports supplements, energy drinks, and othe... Read More »
May 2021The global hospital acquired infections therapeutic market size was valued at USD 10.3 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 2.4% from 2020 to 2027. The high prevalence of HAIs, approval & launch of new therapies, and increasing R&D ... Read More »
February 2021